{
  "docId": "019de071-4830-7608-84e8-b3f03659010d",
  "docSlug": "f2adf3cca406f89f9f21532698bebce4",
  "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides",
  "authorId": "omega-therapeutics",
  "authorName": "Omega Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7843866,
  "pageNumber": 3,
  "pageCount": 33,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "appendix_data",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 5,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/3",
  "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d",
  "deckJsonHref": "/decks/019de071-4830-7608-84e8-b3f03659010d.json",
  "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.904,
        "x": 0.048,
        "y": 0.175
      },
      "kind": "table",
      "text": "Issuer (Exchange / Ticker) Omega Therapeutics, Inc. (NASDAQ Global Market / OMGA) Base Offering Size $125 million (100% primary) Shares Offered 7,400,000 shares (100% primary) Option to Purchase Additional Shares 1,110,000 shares (100% primary) Price Range $16.00 - $18.00 per share Lock-Up Period 180 day lock up of the Company, Directors, Officers, and Substantially All Shareholders Use of Proceeds Omega Therapeutics intends to use the net proceeds from the offering as follows: to support Omega's continued research and development of its OECs to support IND-enabling studies and the potential initiation of clinical studies to continue advancing the OMEGA Epigenomic Programming Platform and discovery-stage research for other potential programs to build out a manufacturing facility for working capital and other general corporate purposes Bookrunners Goldman Sachs & Co. LLC, Jefferies LLC, Piper Sandler & Co., Wedbush Securities Inc. Stabilization Agent Goldman Sachs & Co. LLC Expected Pricing Date Thursday, July 29, 2021",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f030cc55-2e0c-4e99-9b69-be28c5cce99c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.315,
        "x": 0.048,
        "y": 0.085
      },
      "kind": "title",
      "text": "IPO Offering Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1388a102-d704-44ad-88b1-e0a7216401a8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "2b27d6b9-a753-4e6e-bdb1-89d7cececd41",
      "evidence": "table/data: Issuer (Exchange / Ticker) Omega Therapeutics, Inc. (NASDAQ Global Market / OMGA) Base Offering Size $125 million (100% primary) Shares Offered 7,400,000 shares (100% primary) Option to Purchase Additional Sh",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}